United Therapeutics Corp (UTHR)
264.32
-1.58
(-0.60%)
USD |
NASDAQ |
May 10, 16:00
264.32
0.00 (0.00%)
After-Hours: 20:00
United Therapeutics Price to Book Value: 2.197 for May 10, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 09, 2024 | 2.210 |
| May 08, 2024 | 2.17 |
| May 07, 2024 | 2.213 |
| May 06, 2024 | 2.165 |
| May 03, 2024 | 2.181 |
| May 02, 2024 | 2.145 |
| May 01, 2024 | 2.120 |
| April 30, 2024 | 1.948 |
| April 29, 2024 | 1.980 |
| April 26, 2024 | 1.943 |
| April 25, 2024 | 1.961 |
| April 24, 2024 | 1.969 |
| April 23, 2024 | 1.947 |
| April 22, 2024 | 1.944 |
| April 19, 2024 | 1.976 |
| April 18, 2024 | 1.968 |
| April 17, 2024 | 1.954 |
| April 16, 2024 | 1.925 |
| April 15, 2024 | 1.952 |
| April 12, 2024 | 1.926 |
| April 11, 2024 | 1.965 |
| April 10, 2024 | 1.969 |
| April 09, 2024 | 1.963 |
| April 08, 2024 | 1.962 |
| April 05, 2024 | 1.934 |
| Date | Value |
|---|---|
| April 04, 2024 | 1.937 |
| April 03, 2024 | 1.915 |
| April 02, 2024 | 1.893 |
| April 01, 2024 | 1.890 |
| March 31, 2024 | |
| March 28, 2024 | 1.806 |
| March 27, 2024 | 1.913 |
| March 26, 2024 | 1.949 |
| March 25, 2024 | 1.921 |
| March 22, 2024 | 1.871 |
| March 21, 2024 | 1.863 |
| March 20, 2024 | 1.861 |
| March 19, 2024 | 1.882 |
| March 18, 2024 | 1.840 |
| March 15, 2024 | 1.854 |
| March 14, 2024 | 1.872 |
| March 13, 2024 | 1.897 |
| March 12, 2024 | 1.941 |
| March 11, 2024 | 1.962 |
| March 08, 2024 | 1.911 |
| March 07, 2024 | 1.887 |
| March 06, 2024 | 1.863 |
| March 05, 2024 | 1.807 |
| March 04, 2024 | 1.799 |
| March 01, 2024 | 1.824 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.253
Minimum
Mar 18 2020
2.802
Maximum
Dec 09 2022
1.990
Average
1.996
Median
Apr 04 2022
Price to Book Value Benchmarks
| Liquidia Corp | 19.46 |
| Ligand Pharmaceuticals Inc | 1.940 |
| Esperion Therapeutics Inc | -- |
| Vertex Pharmaceuticals Inc | 5.883 |
| Heron Therapeutics Inc | -- |
Price to Book Value Related Metrics
| PE Ratio | 12.50 |
| PS Ratio | 5.261 |
| PEG Ratio | 0.2946 |
| Price to Free Cash Flow | 17.47 |
| Price | 264.32 |
| Earnings Yield | 8.00% |
| Market Cap | 11.73B |
| PEGY Ratio | 0.2946 |
| Operating PE Ratio | 10.46 |
| Normalized PE Ratio | 12.50 |